Synergistic effect of anethole and doxorubicin alleviates cell proliferation, cell cycle arrest, and ER stress and promotes ROS‐mediated apoptosis in triple‐negative breast cancer cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic effect of anethole and doxorubicin alleviates cell proliferation, cell cycle arrest, and ER stress and promotes ROS‐mediated apoptosis in triple‐negative breast cancer cells
Authors
Keywords
-
Journal
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
Volume 35, Issue 12, Pages -
Publisher
Wiley
Online
2021-09-29
DOI
10.1002/jbt.22928
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brevilin A Inhibits STAT3 Signaling and Induces ROS-Dependent Apoptosis, Mitochondrial Stress and Endoplasmic Reticulum Stress in MCF-7 Breast Cancer Cells
- (2020) Muhammad Zubair Saleem et al. OncoTargets and Therapy
- GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer
- (2020) Jintao Lin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Recent advances in triple negative breast cancer: the immunotherapy era
- (2019) Antonio Marra et al. BMC Medicine
- Bursopentin (BP5) induces G1 phase cell cycle arrest and endoplasmic reticulum stress/mitochondria-mediated caspase-dependent apoptosis in human colon cancer HCT116 cells
- (2019) Jing Li et al. Cancer Cell International
- ROS-Mediated Cancer Cell Killing through Dietary Phytochemicals
- (2019) Saranya NavaneethaKrishnan et al. Oxidative Medicine and Cellular Longevity
- The Anticancer and Antioxidant Effects of Muscadine Grape Extracts on Racially Different Triple-negative Breast Cancer Cells
- (2019) PATRICIA MENDONCA et al. ANTICANCER RESEARCH
- Oxidative stress injury in doxorubicin-induced cardiotoxicity
- (2019) Mei Songbo et al. TOXICOLOGY LETTERS
- Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94
- (2019) Francesca Caccuri et al. Cancers
- Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells
- (2019) Naoya Yamashita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An anti-cancerous protein fraction from Withania somnifera induces ROS-dependent mitochondria-mediated apoptosis in human MDA-MB-231 breast cancer cells
- (2019) Parvaiz A. Dar et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
- (2019) Megan Stevens et al. Frontiers in Genetics
- Recent advances in nanotheranostics for triple negative breast cancer treatment
- (2019) Vikram Thakur et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis
- (2018) Ayman I. Elkady Anti-Cancer Agents in Medicinal Chemistry
- MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
- (2018) Yaming Li et al. Cell Death & Disease
- Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells
- (2017) Haribalan Perumalsamy et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Induction of intrinsic apoptotic pathway and cell cycle arrest via baicalein loaded iron oxide nanoparticles as a competent nano-mediated system for triple negative breast cancer therapy
- (2016) Krishnamoorthy Kavithaa et al. RSC Advances
- PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis
- (2011) Kexiong Zhang et al. Molecular Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More